TY - JOUR
T1 - DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association
AU - Lakis, Vanessa
AU - Lawlor, Rita T.
AU - Newell, Felicity
AU - Patch, Ann Marie
AU - Mafficini, Andrea
AU - Sadanandam, Anguraj
AU - Koufariotis, Lambros T.
AU - Johnston, Rebecca L.
AU - Leonard, Conrad
AU - Wood, Scott
AU - Rusev, Borislav
AU - Corbo, Vincenzo
AU - Luchini, Claudio
AU - Cingarlini, Sara
AU - Landoni, Luca
AU - Salvia, Roberto
AU - Milella, Michele
AU - Chang, David
AU - Bailey, Peter
AU - Jamieson, Nigel B.
AU - Duthie, Fraser
AU - Gingras, Marie Claude
AU - Muzny, Donna M.
AU - Wheeler, David A.
AU - Gibbs, Richard A.
AU - Milione, Massimo
AU - Australian Pancreatic Genome Initiative (APGI)
AU - Chantrill, Lorraine A.
AU - Timpson, Paul
AU - Chou, Angela
AU - Pajic, Marina
AU - Murphy, Angela
AU - Dwarte, Tanya
AU - Hermann, David
AU - Vennin, Claire
AU - Cox, Thomas R.
AU - Pereira, Brooke
AU - Ritchie, Shona
AU - Reed, Daniel A.
AU - Chambers, Cecilia R.
AU - Metcalf, Xanthe
AU - Nobis, Max
AU - Mukhopadhyay, Pamela
AU - Addala, Venkateswar
AU - Kazakoff, Stephen
AU - Holmes, Oliver
AU - Xu, Qinying
AU - Hofmann, Oliver
AU - Pavlakis, Nick
AU - Arena, Jennifer
AU - High, Hilda A.
AU - Asghari, Ray
AU - Merrett, Neil D.
AU - Pavey, Darren
AU - Das, Amitabha
AU - Cosman, Peter H.
AU - Ismail, Kasim
AU - O’Connnor, Chelsie
AU - Stoita, Alina
AU - Williams, David
AU - Spigellman, Allan
AU - Lam, Vincent W.
AU - McLeod, Duncan
AU - Kirk, Judy
AU - Kench, James G.
AU - Grimison, Peter
AU - Sandroussi, Charbel
AU - Goodwin, Annabel
AU - Mead, R. Scott
AU - Tucker, Katherine
AU - Andrews, Lesley
AU - Texler, Michael
AU - Forest, Cindy
AU - Ballal, Mo
AU - Fletcher, David R.
AU - Zeps, Nikolajs
AU - Nguyen, Nan Q.
AU - Ruszkiewicz, Andrew R.
AU - Worthley, Chris
AU - Chen, John
AU - Brooke-Smith, Mark E.
AU - Papangelis, Virginia
AU - Clouston, Andrew D.
AU - Barbour, Andrew P.
AU - O’Rourke, Thomas J.
AU - Fawcett, Jonathan W.
AU - Slater, Kellee
AU - Hatzifotis, Michael
AU - Hodgkinson, Peter
AU - Nikfarjam, Mehrdad
AU - Eshleman, James R.
AU - Hruban, Ralph H.
AU - Wolfgang, Christopher L.
AU - Dixon, Judith
AU - ARC-Net
AU - Scardoni, Maria
AU - Bassi, Claudio
AU - Grimaldi, Sonia
AU - Cantù, Cinzia
AU - Bonizzato, Giada
AU - Bersani, Samantha
AU - Antonello, Davide
AU - Piredda, Liliana
AU - Sperandio, Nicola
AU - Barbi, Stefano
AU - Merlini, Paola
AU - Pederzoli, Paolo
AU - Samra, Jaswinder S.
AU - Gill, Anthony J.
AU - Johns, Amber L.
AU - Pearson, John V.
AU - Biankin, Andrew V.
AU - Grimmond, Sean M.
AU - Waddell, Nicola
AU - Nones, Katia
AU - Scarpa, Aldo
N1 - Copyright the Author(s) 2021. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.
PY - 2021/2/3
Y1 - 2021/2/3
N2 - Here we report the DNA methylation profile of 84 sporadic pancreatic neuroendocrine tumors (PanNETs) with associated clinical and genomic information. We identified three subgroups of PanNETs, termed T1, T2 and T3, with distinct patterns of methylation. The T1 subgroup was enriched for functional tumors and ATRX, DAXX and MEN1 wild-type genotypes. The T2 subgroup contained tumors with mutations in ATRX, DAXX and MEN1 and recurrent patterns of chromosomal losses in half of the genome with no association between regions with recurrent loss and methylation levels. T2 tumors were larger and had lower methylation in the MGMT gene body, which showed positive correlation with gene expression. The T3 subgroup harboured mutations in MEN1 with recurrent loss of chromosome 11, was enriched for grade G1 tumors and showed histological parameters associated with better prognosis. Our results suggest a role for methylation in both driving tumorigenesis and potentially stratifying prognosis in PanNETs.
AB - Here we report the DNA methylation profile of 84 sporadic pancreatic neuroendocrine tumors (PanNETs) with associated clinical and genomic information. We identified three subgroups of PanNETs, termed T1, T2 and T3, with distinct patterns of methylation. The T1 subgroup was enriched for functional tumors and ATRX, DAXX and MEN1 wild-type genotypes. The T2 subgroup contained tumors with mutations in ATRX, DAXX and MEN1 and recurrent patterns of chromosomal losses in half of the genome with no association between regions with recurrent loss and methylation levels. T2 tumors were larger and had lower methylation in the MGMT gene body, which showed positive correlation with gene expression. The T3 subgroup harboured mutations in MEN1 with recurrent loss of chromosome 11, was enriched for grade G1 tumors and showed histological parameters associated with better prognosis. Our results suggest a role for methylation in both driving tumorigenesis and potentially stratifying prognosis in PanNETs.
UR - http://www.scopus.com/inward/record.url?scp=85100523728&partnerID=8YFLogxK
UR - http://purl.org/au-research/grants/nhmrc/631701
UR - http://purl.org/au-research/grants/nhmrc/535903
U2 - 10.1038/s42003-020-01469-0
DO - 10.1038/s42003-020-01469-0
M3 - Article
C2 - 33536587
AN - SCOPUS:85100523728
SN - 2399-3642
VL - 4
SP - 1
EP - 11
JO - Communications Biology
JF - Communications Biology
IS - 1
M1 - 155
ER -